Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Neutral

Analyst Rating

Neutral

Simple Moving Average

Strong Sell

Exponential Moving Average

Sell

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

BioAtla, Inc. Common Stock (BCAB)

Biological Products, (no Disgnostic Substances)

https://www.bioatla.com

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of highly specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise Mecbotamab vedotin, Ozuriftabmab vedotin, BA3071, and Bispecific antibody programs.

11085 TORREYANA ROAD
SAN DIEGO, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

12/16/2020

Market Cap

91,837,830

Shares Outstanding

47,800,000

Weighted SO

47,935,808

Total Employees

N/A

Upcoming Earnings

08/08/2024

Beta

1.0480

Last Div

0.0000

Range

1.14-4.02

Chg

0.0200

Avg Vol

946432

Mkt Cap

91837830

Exch

NASDAQ

Country

US

Phone

858 558 0708

DCF Diff

-0.4216

DCF

2.2816

Div Yield

0.0000

P/S

53.8323

EV Multiple

-0.2917

P/FV

2.9203

Div Yield %

0.0000

P/E

-0.8762

PEG

-0.1971

Payout

0.0000

Current Ratio

3.8079

Quick Ratio

3.8079

Cash Ratio

3.5312

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

447.1003

CCC

-447.1003

Gross Margin

0.3511

Op Margin

-64.4695

Pretax Margin

-61.2872

Net Margin

-61.2872

Eff Tax Rate

-0.0299

ROA

-1.5233

ROE

-1.6969

ROCE

-2.1492

NI/EBT

1.0000

EBT/EBIT

0.9506

EBIT/Rev

-64.4695

Debt Ratio

0.0242

D/E

0.0530

LT Debt/Cap

0.0000

Total Debt/Cap

0.0503

Int Coverage

-74.8197

CF/Debt

-64.5535

Equity Multi

2.1880

Rec Turnover

0.0000

Pay Turnover

0.8164

Inv Turnover

0.0000

FA Turnover

0.7953

Asset Turnover

0.0249

OCF/Share

-2.2252

FCF/Share

-2.2259

Cash/Share

1.2789

OCF/Sales

-62.8886

FCF/OCF

1.0003

CF Coverage

-64.5535

ST Coverage

-64.5535

CapEx Coverage

-3251.1515

Div&CapEx Cov

-3251.1515

P/BV

2.9203

P/B

2.9203

P/S

53.8323

P/E

-0.8762

P/FCF

-0.8557

P/OCF

-0.8539

P/CF

-0.8539

PEG

-0.1971

P/S

53.8323

EV Multiple

-0.2917

P/FV

2.9203

DPS

0.0000

Latest Headlines (EST)

Revenue Product Segmentation